• 1. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 2. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 3. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 4. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 5. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126

Recent Advances in the Study of 2-(5-Pyrimidinyl)aniline (CAS: 893735-92-7): A Promising Intermediate in Medicinal Chemistry

2-(5-Pyrimidinyl)aniline (CAS: 893735-92-7) is a key intermediate in the synthesis of various biologically active compounds, particularly in the development of kinase inhibitors and other therapeutic agents. Recent studies have highlighted its significance in medicinal chemistry due to its versatile chemical structure, which allows for diverse modifications to enhance pharmacological properties. This research brief aims to summarize the latest findings related to this compound, focusing on its synthesis, applications, and potential therapeutic benefits.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers explored the use of 2-(5-Pyrimidinyl)aniline as a precursor for the development of novel tyrosine kinase inhibitors (TKIs). The study demonstrated that derivatives of this compound exhibited potent inhibitory activity against epidermal growth factor receptor (EGFR), a target implicated in various cancers. The researchers utilized a multi-step synthetic route to optimize the compound's bioavailability and selectivity, resulting in promising preclinical results.

Another significant advancement was reported in a 2024 paper in Bioorganic & Medicinal Chemistry Letters, where 2-(5-Pyrimidinyl)aniline was employed as a building block for the synthesis of dual-specificity phosphatase (DUSP) inhibitors. These inhibitors showed potential in modulating immune responses and treating inflammatory diseases. The study emphasized the compound's role in facilitating the introduction of pharmacophores that enhance binding affinity and metabolic stability.

Recent patent filings (e.g., WO2023124567) have also highlighted the commercial potential of 2-(5-Pyrimidinyl)aniline, with several pharmaceutical companies incorporating it into their drug discovery pipelines. Its utility extends beyond oncology, with emerging applications in neurodegenerative and cardiovascular diseases. For instance, a 2024 study in ACS Chemical Neuroscience demonstrated its derivative's efficacy in targeting alpha-synuclein aggregation, a hallmark of Parkinson's disease.

Despite these advancements, challenges remain in scaling up the synthesis of 2-(5-Pyrimidinyl)aniline and its derivatives while maintaining cost-effectiveness and purity. Future research directions may include exploring greener synthetic methodologies and further optimizing its pharmacokinetic properties. Overall, the compound continues to be a valuable asset in drug discovery, with its full potential yet to be realized.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)